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The WNT-signaling pathway plays a major role during mammalian embryogenesis. We report a novel autosomal-recessive syndrome
that consists of female to male sex reversal and renal, adrenal, and lung dysgenesis and is associated with additional developmental
defects. Using a candidate-gene approach, we identiﬁed a disease-causing homozygous missense mutation in the human WNT4
gene. The mutation was found to result in markedly reduced WNT4 mRNA levels in vivo and in vitro and to downregulate WNT4-
dependant inhibition of b-catenin degradation. Taken together with previous observations in animal models, the present data attribute
a pivotal role to WNT4 signaling during organogenesis in humans.Introduction
The deciphering of the molecular machinery underlying
a developmental process can have far-reaching conse-
quences, given that many physiological (e.g., wound re-
pair) and pathological (e.g., cancer) events in the adult
organism often grossly recapitulate major phases of embry-
onic development.1,2 Gonadal differentiation is consid-
ered as one of the most complex and puzzling develop-
mental processes in humans. The presence or absence of
a Y chromosome is known to determine the subsequent
formation of the primordial gonad into a testis or an ovary,
respectively.3 Genetically engineered mice have revealed
the role of a large number of molecules involved in the
formation of the reproductive system, among which
WNT4 is considered as most important for the proper dif-
ferentiation of female gonadal tissues.4 WNT4 has been
shown to play a critical role not only in the development
of the reproductive system but also in the formation of
the kidneys, adrenals, pituitary gland, and mammary
tissues.5 WNT4 belongs to the WNT family, a large group
of secreted glycoproteins encoded by 19 distinct genes
in the vertebrate genome, which are expressed and func-
tion in a tissue-speciﬁc fashion and have been shown
to play key roles in the development of multicellular
animals.6,7
In the present report, we delineate for the ﬁrst time (to
our knowledge) the clinical features and molecular abnor-
malities associated with a homozygous null mutation in
WNT4 in humans. Our data demonstrate that the protein
encoded by this gene plays an essential role in human
sex-determination and organogenesis.TheMaterial and Methods
Patients and Biological Materials
Blood samples were obtained from each living participant after in-
formed and written consent (according to a protocol reviewed and
approved by the local Helsinki Committee and by the National
Committee for Genetic Studies of the Israeli Ministry of Health)
was received. Fifteen milliliters of blood were drawn from each in-
dividual, and genomic DNA was isolated from blood samples via
the salt-chloroform extraction method. Autopsies were performed
and tissues samples were obtained for histology or DNA and/or
RNA extraction after informed and written consent from both par-
ents of each aborted fetus was received. DNA was extracted from
parafﬁn-embedded specimens with QiAmp DNA kit (QIAGEN,
Valencia, CA) according to the manufacturer’s instructions.
Microsatellite Analysis
Polymorphicmicrosatellitemarkers spanning theWNT4 locus were
selected fromtheGDBdatabase,Genotypeswere establishedbyPCR
ampliﬁcationofgenomicDNAwithSuperthermTaqpolymerase (Ei-
senberg Brothers, Givat Schmuel, Israel) and ﬂuorescently labeled
primer pairs (Research Genetics, InVitrogen, Carlsbad, CA) according
to the manufacturer’s recommendations. PCR conditions were 5 min
at 95 C followed by 35 cycles for 30 s at 95 C, 30 s at 56 C, 30 s at
72 C, and a ﬁnal extension step at 72 C for 5 min. PCR products
were separated by PAGEon anABI 310 sequencer system, and allele
sizes were determined with Genescan 3.1 and Genotyper 2.0 soft-
ware. Parsimonious haplotypes were subsequently established for
each individual.
Mutation Analysis
GenomicDNAwas PCR-ampliﬁedwith primer pairs encompassing
all exons and exon-intron boundaries of the WNT4 gene (acces-
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extraction kit) amplicons were subjected to bidirectional DNA se-
quencing with the BigDye terminator system on an ABI Prism
3100 sequencer (PE Applied Biosystems).
Mutation c.C341T creates a recognition site for endonuclease
HpyCH4IV. Thus, to conﬁrm and screen for mutation c.C341T,
we PCR-ampliﬁed a 699 bp fragment with forward primer 50-GT
GCCTAGCACATGATTTCTGC-30 and reverse primer 50-GTAACG
CCTGCCTGCCTGTCTG-30; the resulting amplicon was digested
with endonuclease HpyCH4IV. To identify the mutation in para-
fﬁn-embedded derived DNA samples, we PCR-ampliﬁed a 231 bp
fragment with forward primer 50-GCAGGAGGCTCCATATGC-30
and reverse primer 50-CACCTACCCTGTGGGCTG-30; the resulting
amplicon was digested with the same endonuclease.
Plasmids
The full-length WNT4 cDNA was cloned into pT-Rex-DEST30
(Invitrogen, CA). c.C314T was introduced into pT-Rex-DEST30-
WNT4 by site-directed mutagenesis with the QuickChange II XL
Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) and with
primers mutwnt4F 50-GCCTTCGTGTACGTCATCTCTTCGGCAG-30
and mutwnt4R 50-CTGCCGAAGAGATGACGTACACGAAGGC-30.
Plasmid sequence was veriﬁed by direct sequencing as described
above.
Cell Cultures
OVCAR3 cells were plated at a density of 4 3 106 in 35 mm 6-well
dishes and cultured in RPMI 1640 supplemented with 20% FCS,
1% L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate (Biologi-
cal Industries, Bet Haemek, Israel). Cells were transfected with 4 mg
plasmid by using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions and collected for further analysis
24 hr later.
Amniocytes were cultured for 48 hr in DMEM supplemented
with 15% FCS (Biological Industries).
Reverse-Transcription Polymerase Chain Reaction
Total RNAwas extracted from cell cultures with the High Pure RNA
Isolation Kit (Roche Diagnostics, Mannheim, Germany). Total
cDNA was synthesized with the Reverse-iT 1st Strand Synthesis
Kit (ABgene, Surrey, UK) and ampliﬁed with Taq polymerase, Q
solution (QIAGEN, Valencia, CA), and intron-crossingWNT4-spe-
ciﬁc primers (forward 50-CTTCGCCGTCTTCTCAG-30 and reverse
50-GTTCCGCTTGCACATCT-30; expected size 138 bp). Cycling
conditions were 95C 5 min followed by 35 cycles at 95C 30 s,
57C 45 s, and 72C 90 s and a ﬁnal extension step at 72C for
7 min. As a control, we ampliﬁed total RNA as described above
with ACTB-speciﬁc primers (forward 50-CCAAGGCCAACCGCGA
GAAGATGAC-30 and reverse 50-AGGGTACATGGTGGTGCCGCC
AGAC-30; expected size 587 bp).
Table 1. Oligonucleotide Sequences for WNT4 Sequencing
Exon Primer Sequence Expected Size
1 Forward GCGGCGCTGACAGCTGGTCCG 413 bp
1 Reverse GGTGTGCAGAGGGACGTTCG 413 bp
2 Forward CAGTCACTGGGACGAGTCAG 444 bp
2 Reverse GTTGCTCACGAGCGTCTCATTTC 444 bp
3–4 Forward GTGCCTAGCACATGATTTCTGC 699 bp
3–4 Reverse GTAACGCCTGCCTGCCTGTCTG 699 bp
5 Forward GCAAATCTGACTGCAGCGTCAG 678 bp
5 Reverse GGGTAGGTGGTGGGAGACTG 678 bp40 The American Journal of Human Genetics 82, 39–47, January 20For quantitative real-time PCR, cDNA PCR ampliﬁcation was car-
ried out with the SYBR Green Jump Start Taq ReadyMix for quanti-
tative PCR (Sigma, Rehovot, Israel) on a real-time quantitative
MX3000P PCR system (Strategene, La Jolla, CA) with primer pairs
speciﬁc for WNT4 (forward 50-GCCTCGTCCAGCAGAGC-30 and
reverse 50-GAACTGTGCGTTGCGTG-30) or ACTB (forward 50-TTG
CCGACAGGATGCAGAAGGA-30 and reverse 50-AGGTGGACAGC
GAGGCCAGGAT-30). To ensure the speciﬁcity of the reaction con-
ditions, at the end of the individual runs, wemeasured themelting
temperature (Tm) of the ampliﬁed products to conﬁrm its homoge-
neity. Cycling conditionswere as follows: 95C for 10min; 95C for
15 s, 60C for 15 s, and 72C for 15 s for a total of 40 cycles. Each
sample was analyzed in triplicate. For quantiﬁcation, standard
curves were obtained with serially diluted cDNA ampliﬁed in the
same real-time PCR run. Results were normalized to ACTB mRNA
levels. After the quantiﬁcation procedure, the products were re-
solved by 2.5% agarose gel electrophoresis to conﬁrm that the
reaction had ampliﬁed the correct DNA fragments of known size.
Western Blotting
Cells were homogenized in lysis buffer (25 mM HEPES, 300 mM
NaCl, 1.5mMMgCl2, 0.2mMEDTA, 0.1%TritonX-100, andprote-
ase inhibitormix including1mMPMSF, 1mg/ml aprotininand leu-
peptin; Sigma). Following centrifugation at 10,0003 g for 10minat
4C, proteins were electrophoresed through a 10% SDS-PAGE and
transferred onto a nitrocellulose membrane (Trans-Blot, Bio-Rad,
Hercules, CA). After 1 hr blocking with 13 TBS (20 mM Tris,
150 mM NaCl) with 5% skim milk and 0.01% Tween 20, blots
were incubated with anti-b-catenin polyclonal antibody (Cell Sig-
nalingTechnology, Beverly,MA). Theblotswerewashed three times
with 13 TBS, 0.05% Tween-20. After incubation with secondary
HRP-conjugated antibodies (Sigma) and subsequent washings, pro-
teins were detected with the EZ-ECL chemiluminescence detection
kit (Biological Industries). In order to compare the amount of pro-
tein in the different samples, we reprobed the blots with an anti-
b-actin monoclonal antibody (Abcam, Cambridge, MA).
Gas-Chromatography Mass-Spectrometry (GC-MS)
Proﬁling of Urinary Steroids
Urinary-steroid proﬁles were determined from spot urine speci-
mens as previously reported with few changes.8 An aliquot of
urine was processed by solid-phase extraction, hydrolysis, re-ex-
traction, and derivatization and puriﬁed by gel chromatography.
Gas chromatography was performed with an Optima-1 fused col-
umn, and heliumwas used as carrier gas at a ﬂow rate of 1 ml/min.
The gas chromatograph (Agilent 6890) was directly interfaced to
a mass selective detector (Agilent 5972A) operated in selected
ion monitoring (SIM) mode.
Bioinformatics
Sequence alignment was performed with MAFFT, a multiple-
sequence alignment program. mRNA secondary structure was
predicted with the GeneBee RNA secondary-structure prediction
software.
Results
Clinical and Pathological Features
We studied a consanguineous kindred of Arab Muslim
origin (Figure 1A). This family has been followed since08
the birth of a full-term male (II-10) who died of hyperam-
monemia due to citrullinemia type I (MIM 215700) at age
4 days. The parents of this patient (I-3 and I-4) are 2nd-
degree cousins. The family chose to interrupt a ﬁrst preg-
Figure 1. Pedigree Structure and Path-
ological Features
(A) Family pedigree and haplotype analysis
using polymorphic microsatellite markers
on 1p36.23-p35.1. The disease-associated
haplotype is boxed in red. The position of
the WNT4 gene is indicated.
(B–I) Histopathogical examination of tis-
sues obtained from affected fetuses (B, D,
F, and H) and from a normal 19-week-old
fetus (C, E, G, and I). Affected 46,XX fetus
II-12 displays (B) a normal-looking testis
(sex reversal) with coiled seminiferous tu-
bules and numerous Leydig cells through-
out the interstitium as compared with the
testis of an 46,XY healthy fetus (C); af-
fected fetus II-6 demonstrates both testic-
ular (‘‘T’’) and ovarian (‘‘O’’) tissues (D)
including seminiferous tubules (‘‘ST’’), Ley-
dig cells (‘‘LC’’), and primordial follicles
(‘‘PF’’) (E); the kidney of affected fetus
II-12 (F) showed a very thin rim of nephro-
genic zone, with decreased numbers of
mature glomeruli, and very few proximal
tubules with immature interstitial tissue
resembling undifferentiated mesenchyme
of dysplastic kidney as compared with
a normal fetal kidney at 19 weeks of gesta-
tion (G), where the numerous glomeruli
identify the renal cortex; examination of
lung tissues of affected fetus II-2 (H) re-
vealed focal marked dilatation of distal
airways compared with control fetal lung
tissue (I) (magnification, 503 [B and C],
1003 [D, F, G, H, and I], 4003 [E]).
nancy at gestation age 24 weeks (II-
6) and a second pregnancy at 19
weeks of gestation (II-12) after ultra-
sonic ﬁnding of renal agenesis in
both cases. This couple reported three
other ﬁrst-trimester spontaneous mis-
carriages (II-7, II-8, II-11). Reportedly,
another member of the family (I-2)
underwent termination of pregnancy
in the 23rd week of gestation (II-2) be-
cause of similar ultrasonic ﬁndings of
renal agenesis. In all three cases (II-2,
II-6, II-12), a presumptive diagnosis
of Potter syndrome was entertained.
The macroscopic pathological ﬁnd-
ings of autopsies of three fetuses (II-2,
II-6, II-12) are summarized in Table 2.
Examination of fetus II-12 revealed
a small-for-gestational-age male fetus, with cleft lip and
palate, cardiac ventricular septal defect, pulmonary artery
stenosis, and small lungs. Neither kidneys nor adrenal
glands were identiﬁed on gross pathologic examination.The American Journal of Human Genetics 82, 39–47, January 2008 41
Table 2. SERKAL Syndrome: Phenotypic Features
Affected Fetuses (year of birth) II-2 (1990) II-6 (2000) II-12 (2006)
Termination of pregnancy (age weeks) 23 24 19
Ultrasound
Growth retardation þ þ þ
Renal agenesis þ þ þ
Oligohydramnion þ þ þ
Presumptive diagnosis: Potter syndrome þ þ þ
Maternal serum estriol ND* low low
Macroscopic Pathological Findings
Renal agenesis/dysgenesis þ þ þ
Hypoplastic lungs þ CCAM* þ þ
Adrenal Small NR not found
Cleft lip/palate þ  þ
Congenital heart disease   VSD* and pulmonary
stenosis
Diaphragmatic hernia  only remnant of diaphragma; liver
surrounding the heart

Intestine malrotation þ  
Urinary bladder NR hypoplastic hypoplastic
External genitalia (testis/ovum) Female NR Male: distorted penis and hypospadias
(ovotestis)
Male genitalia
(testis)
The following abbreviations (*) are used: ND, not done; NR, not reported; CCAM, congenital cystic adenomatoid malformation; and VSD, ventricular septal
defect.Histopathological studies of this fetus revealed apparently
normal-looking testes (Figure 1B), minute kidneys with
markedly decreased numbers of normal mature glomeruli
and paucity of proximal tubules (Figure 1F), a hypoplastic
urinary bladder with thin ureters, and exceedingly small
adrenals with seemingly normal morphology (not shown).
Despite the presence of male gonads, cytogenetic analysis
revealed a normal 46,XX female karyotype, suggestive of
female to male sex reversal. PCR ampliﬁcation of genomic
DNA derived from this fetus revealed absence of SRY (not
shown), a Y chromosome-encoded gene; this result sup-
ports the cytogenetic diagnosis.
The two other fetuses assessed displayed similar features.
Pathological examination of fetus II-6 (Table 2) disclosed
a 24-week-old fetus, with a curved penis and hypospadias,
bilateral diaphragmatic hernia with the liver surrounding
the heart, small lungs and a single kidney remnant with
disorganized glomeruli and tubuli, and rudimentary uri-
nary bladder and ovotestes (Figure 1D). Fetus II-2 was
a 23-week-old fetus with low-set ears, facial features resem-
bling Potter syndrome, bilateral cleft lip and palate, hypo-
plastic lungs, renal agenesis, and undersized adrenal glands
with normal microscopic morphology. This fetus also
displayed severe focal dilation of distal airways in one
lung, reminiscent of congenital cystic adenomatoid mal-
formation (Figure 1H).
Given that affected fetuses featured largely overlapping
features including (1) female sex reversal and dysgenesis
of (2) kidneys, (3) adrenals, and (4) lungs, we named this
novel autosomal-recessive phenotype SERKAL syndrome.42 The American Journal of Human Genetics 82, 39–47, January 200Identiﬁcation of a Causative Mutation in WNT4
The high degree of inbreeding characterizing the family
under study and the clinical and pathological ﬁndings
reviewed above were suggestive of a lethal recessive disor-
der caused by a mutation in a gene coding for a protein
involved in both sex determination and organogenesis.
Given the similarities between the present cases (II-2,II-6,
II-12) and a WNT4 knocked-out mouse model previously
described,5,9–11 we genotyped all available family members
for microsatellite markers spanning the WNT4 locus. The
affected fetus from which DNA was available (II-12) dis-
played a homozygous haplotype, which was found to be
carried in a heterozygous state by all parents and siblings
(Figure 1A), suggesting the existence of a homozygous
mutation in WNT4 in the affected fetus.
Accordingly, direct sequencing of the entire coding
sequence of theWNT4 gene in this fetus revealed the pres-
ence of a homozygous C/ T transition at cDNA position
341 (c.C341T) (Figure 2A). The mutation was found to be
carried in a heterozygous state by all parents and siblings.
The mutation is predicted to result in the substitution of
a valine residue for an alanine residue at amino acid posi-
tion 114 (p.A114V). Using a PCR-RFLP assay, we conﬁrmed
segregation of the mutation in the family (Figure 2B) and
excluded it from a panel of 300 population-matched
healthy unrelated individuals (600 chromosomes), sug-
gesting that this sequence variant does not represent
a common nonconsequential polymorphism. We con-
ﬁrmed the presence of homozygous c.C341T mutation in
the two affected fetuses from whom cells or blood samples8
Figure 2. Mutation Analysis
(A) Sequence analysis revealed in an affected fetus (II-12) a homozygous transition (c.C341T) (blackened letter, upper panel), resulting
in amino acid substitution A114V. The wild-type sequence is given for comparison (lower panel).
(B) c.C314T creates a novel recognition site for HpyCH4IV endonuclease. A 699 bp fragment was amplified as described in Material and
Methods and digested with HpyCH4IV. The affected fetus displays two fragments, of 172 bp and 527 bp, that are carried in a heterozygous
state by all other family members.
(C) The amino acid (upper panel) and cDNA (lower panel) sequences of human WNT4 were compared to those of other human WNT proteins
and WNT4 orthologs in other species. Note the high degree of conservation of both amino acid A114 (upper panel) and nucleotide C341
(lower panel).were not available by using DNA extracted from parafﬁn-
embedded blocks and a PCR-RFLP assay (not shown).
Delineation of the Consequences of c.C341TMutation
The c.C341T mutation affects a highly conserved alanine
residue found in all human WNT proteins as well as in
WNT4 orthologs in all living organisms for which WNT4
sequence is known, including zebraﬁsh and Drosophila
(Figure 2C), suggesting that it might be of functional im-
portance. Upon secretion, WNT proteins bind to the friz-
zled family of receptors and activate a number ofmolecular
pathways—an activation that might result in b-catenin
stabilization, and, as a consequence, increased transcrip-
tional activity.6 WNT4 has been shown to be able to acti-
vate this canonical pathway.12 We therefore transfected
OVCAR3 cells with wild-type and p.A114V-carrying full-
length WNT4 cDNA-expression vectors. Whereas the
wild-type vector led to a signiﬁcant increase in b-catenin
protein levels, as expected and as previously reported,12
no change, compared tobaseline,wasobserved inb-catenin
levels in cells transfected with the mutant vector, suggest-
ing that p.A114Vmutation indeed abolishesWNT4activity
(Figure 3A).
To determine the mechanism underlying decreased
WNT4 activity in this cell-based assay, we assessed WNT4
gene expression. In the course of this study, individual
I-4 became pregnant and underwent chorionic villus sam-
pling (CVS) in the 11th week of gestation. Direct sequenc-Theing of genomic DNA extracted from CVS revealed that the
fetus (II-13) carried a homozygous mutation in ASS encod-
ing argininosuccinate synthetase (p.E191K), known to be
associated with citrullinemia in this family, as well as
homozygous c.C341T mutation in WNT4. After parental
informed consent was obtained in writing, total RNA was
extracted from fetal amniocytes obtained during termina-
tion of pregnancy at week 13. Surprisingly, using either
standard RT-PCR (Figure 3B) or quantitative RT-PCR (Fig-
ure 3C), we were unable to detect WNT4 RNA in fetal
amniocytes. This could not have been due to nonspeciﬁc
RNA degradation because ACTB RNA levels were compara-
ble in wild-type and mutant amniocytes.
These results suggested that c.C341T might affect mRNA
stability. A number of mRNA-surveillance mechanisms
have been reported, including nonsense-mediated mRNA de-
cay, leading to degradation of mRNA species carrying non-
sense mutations; non-stop decay, associated with absence of
native stop codons; and a recently described form of mRNA
decay called no-go decay, triggered by ribosome stalling,
whichprobably results from its inability todisrupt conserved
mRNA secondary structures.13 As shown in Figure 2C, C341
and neighboring nucleotides are extremely well-preserved
throughout evolution to an extent that highly suggests
conservation at the RNA level. This prompted us to examine
the effect of c.C341T on the putative secondary structure
of WNT4 mRNA. Computational analysis indicates that
c.C341T signiﬁcantly affects WNT4 mRNA predictedAmerican Journal of Human Genetics 82, 39–47, January 2008 43
Figure 3. Consequences of Mutation
c.C341T
(A) Western-blot analysis of b-catenin and
b-actin expression in OVCAR3 cells trans-
fected with empty vector (EV), wild-type
WNT4 cDNA (WT), and c.C341T mutant
cDNA (M).
(B) Expression of WNT4 and ACTB, coding
for b-actin, assessed with RT-PCR in amnio-
cytes obtained from an affected embryo
(‘‘A’’) as compared with control amniocytes
(‘‘UA’’).
(C) Quantitative real-time PCR analysis for
gene expression of WNT4 in amniocytes
obtained from an affected embryo (‘‘A’’) as
compared with control amniocytes (‘‘UA’’)
(bars represent standard errors). Expres-
sion levels are expressed as absolute values
normalized relative to ACTB RNA levels.
(D) Predicted secondary structures of wild-
type (‘‘WT’’) and c.C314T mutant WNT4 RNA
spanning exon 3. The position of c.C341T
and mutations resulting in a similar change
in mRNA secondary structure are marked
with arrows.
(E) Quantitative real-time PCR analysis for
gene expression of WNT4 in OVCAR3 cells
transfected with empty vector (‘‘EV’’),
wild-type WNT4 cDNA (‘‘WT’’), and c.C341T
mutant cDNA (‘‘M’’). Expression levels are
expressed as absolute values normalized
relative to ACTB RNA levels (bars represent
standard errors).
(F) Chromatograms (GC-MS, SIM mode) of
urinary-steroid hormones. In both parents,
5-a/5-b isomer ratios [Androsterone/Etio-
cholanolone(1,2);11-OH-Androsterone/
11-OH-etiocholanolone (3,4); a-tetrahy-
drocorticosterone (THB)/b-THB (5,6);
a-tetrahydrocortisol (THF)/b-THF (7,8)],
reveal an excess of activity of the enzyme
5-alpha-reductase. The 5a-isomers are 1,
3, 6, and 8; the 5b-isomers are 2, 4, 5,
and 7.44 The American Journal of Human Genetics 82, 39–47, January 2008
structure (Figure 3D). Other mutations in the region sur-
roundingC341have a similarly deleterious effect on the pre-
dicted structure ofWNT4mRNA,whereasmutations located
distally to this region have only a marginal inﬂuence on the
mRNA structure (data not shown). These results are consis-
tent with the possibility that the c.C341T mutation destabi-
lizesWNT4mRNA.
To further assess this hypothesis, we measured RNA level
in OVCAR3 cells transfected with wild-type and c.C341T-
mutation-carrying vectors. Although both genes were tran-
scribed by the same CMV promoter, supposedly driving
the same degree of transcriptional activity, the level of
the mutant transcript was 2.8- to 3-fold lower than that
of the wild-type transcript (Figure 3E).
Steroid Proﬁling of Healthy Carriers of a Deleterious
WNT4 Mutation
Despite being carriers of a deleterious mutation in WNT4,
all four parents displayed a normal phenotype and a
normal serum-steroid proﬁle (not shown). To obtain in
vivo evidence relating the c.C341T mutation to the
XX-male phenotype displayed by the affected fetuses, we
studied the proﬁle of 39 urinary-steroid metabolites in in-
dividual I-3 and I-4. In both asymptomatic heterozygous
parents, we found increased ratios of four 5a/5b isomers
(Figure 3F), indicating elevated activity of 5a-reductase,
responsible for conversion of testosterone to 5a-dihydro-
testosterone (5a-DHT).8
Discussion
Over the past decade, rare congenital disorders have
emerged as a unique source of information on the biolog-
ical pathways determining organogenesis in humans.14–16
In the present study, we delineate the clinical manifesta-
tions and the molecular pathology associated with
a WNT4 null phenotype in humans. Through ascertain-
ment of gene expression in human embryonic cells in
vivo and using an in vitro functional assay, we show that
WNT4 deﬁciency results in severe multisystem develop-
mental anomalies, demonstrating the crucial role played
by this molecule in orchestrating important aspects of
mammalian organogenesis.
Despite its intraexonic position and the fact it affects
a preserved amino acid residue, the WNT4 missense muta-
tion associated with this novel syndrome was shown to
adversely affect mRNA stability, most probably as a result
of disruption of a highly conservedmRNA secondary struc-
ture. This phenomenon has been previously reported in
a small number of cases,17,18 including a recent report
demonstrating that a prevalent polymorphism in the
catechol-O-methyltransferase gene, associated with pain
perception, alters this gene mRNA secondary structure,
thereby regulating enzyme activity and levels by inducing
mRNA degradation.19
Although it is possible that the new phenotype reported
here is rare, it might have been overlooked because of theTheprobably lethal nature of biallelic recessive mutations in
WNT4 as suggested by the present study. Careful patholog-
ical assessment of the three affected fetuses demonstrated
for the ﬁrst time (to our knowledge) the wide range of
developmental anomalies associated with WNT4 deﬁ-
ciency (Table 2). Defective WNT4 activity was found to
affect the development of three major organs (gonads,
kidneys, and adrenal glands), all of which originate from
the primordial urogenital ridge,20 suggesting a pivotal
role for WNT4 at an early embryological stage of develop-
ment.
Similar to previous observations in WNT4-knockout
mice,9,10 we found out that WNT4 deﬁciency resulted in
severe dysgenesis of the kidneys and female to male sex
reversal; in contrast to the murine model, adrenal develop-
ment and external genitalia were also abnormal in human
fetuses. Dominant heterozygous deleterious mutations in
WNT4 have recently been reported in two female individ-
uals with androgen excess, Mullerian duct abnormal devel-
opment but normal female genitalia, and in one case,
unilateral renal agenesis;12,21 these two previously re-
ported missense mutations in WNT4 (R83C and E226G)
were shown to exert a dominant-negative effect on the
expression of two steroidogenic genes, HSD3B2 and
CYP17A1,12,21 which we did not observe when assessing
the effect of c.C341T in the same in vitro system (not
shown). In the present study, we detected elevated ratios
of four urinary 5a/5b isomers in heterozygous parents in-
dicating increased activity of the 5a-reductase (Figure 3F).
These data therefore suggest that WNT4 suppresses 5a-
reductase activity in humans. The most important role of
5a-reductase in humans is the conversion of testosterone
to 5a-DHT, which is much more potent than testosterone
and is responsible for the morphogenesis of the human
male external genitalia.21 We hypothesize that the in-
creased activity of 5a-reductase in heterozygous individual
I-4 was too low to result in the development of male exter-
nal genitalia.
In mammals, WNT4 function was initially studied dur-
ing nephrogenesis because mice lacking WNT4 die shortly
after birth as a result of kidney failure.22 Renal agenesis was
common to all studied fetuses (Table 2). These ﬁndings are
in line with recent studies suggesting in a mouse model
that suboptimal WNT signaling results in renal hypopla-
sia.23 The present observations might indicate that WNT4-
mutation analysis should be considered as part of the
evaluation of bilateral renal dysgenesis, oligohydramnion,
and pulmonary hypoplasia, known as Potter syndrome.24
Abnormal lung development in Potter syndrome is con-
sidered to be a direct consequence of oligohydramnion.
However, it has recently been shown that WNT/b-catenin
signaling is a critical upstream regulator of proximal-distal
patterning of the lungs and of respiratory epithelial cell
differentiation,25,26 which might underlie the marked ab-
normalities identiﬁed in lung tissues in affected fetus II-2.
An important clinical clue that might help in differentiat-
ing the present syndrome from other causes of PotterAmerican Journal of Human Genetics 82, 39–47, January 2008 45
syndrome is very low levels of unconjugated estriol (E3)
in maternal serum, a reliable marker for primary or sec-
ondary adrenal hypoplasia,27 which was observed in
two cases (Table 2). The incidence of developmental disor-
ders of the adrenal gland is probably underestimated be-
cause autopsies do not routinely include thorough inves-
tigation for adrenal pathologies. Whereas no distinct
deviation in size or shape of adrenal glands was demon-
strated in knockout mice,28 c.C341T resulted in marked
reduction in human adrenal size, although histology
was preserved.
In summary, through the delineation of a novel autoso-
mal-recessive phenotype, the present observations demon-
strate the pleiotropic pathological consequences of WNT4
deﬁciency. Given the steadily growing spectrum of physio-
logical pathways regulated through WNT-mediated signal-
ing,6,7 careful clinical assessment andmolecular analysis of
additional cases in the future are likely to further expand
the spectrum of developmental defects associated with
WNT4 mutations.
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